LKFT · Lakefront Biotherapeutics NV · Documents

$32.28 -0.05 (-0.15%) At close · Oct 30 Q1 2026 earnings call transcript

Market Cap

$2.13B

65.90M

Volume · Oct 30 164.06K Avg daily vol (3M) 283.93K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2022-08-24	—
6-K	—	2022-08-19	2022-08-18
6-K	—	2022-08-09	2022-08-08
6-K	—	2022-08-08	—
6-K	—	2022-06-23	2022-06-21
6-K	—	2022-06-23	2022-06-20
6-K	—	2022-06-02	2022-06-01
6-K	—	2022-05-31	2022-05-25
6-K	—	2022-05-11	—
6-K	—	2022-05-09	2022-05-06
6-K	—	2022-05-06	—
6-K	—	2022-04-28	—
6-K	—	2022-04-27	2022-04-26
6-K	—	2022-04-11	—
6-K	—	2022-03-28	—
6-K	—	2022-03-25	2022-03-24
6-K	—	2022-03-24	2022-03-18
20-F	—	2022-03-24	2021-12-31
6-K	—	2022-02-24	—
6-K	—	2022-02-07	2022-02-02
6-K	—	2022-02-07	2022-02-03
6-K	—	2022-01-27	2022-01-26
6-K	—	2022-01-26	—
6-K	—	2022-01-19	2022-01-18
6-K	—	2022-01-13	—
6-K	—	2022-01-10	2022-01-06
6-K	—	2021-12-06	—
6-K	—	2021-11-29	—
6-K	—	2021-11-17	2021-11-15
6-K	—	2021-11-08	—
6-K	—	2021-10-06	2021-10-04
6-K	—	2021-10-06	2021-10-04
6-K	—	2021-09-21	2021-09-20
6-K	—	2021-09-20	2021-09-17
6-K	—	2021-08-31	2021-08-30
6-K	—	2021-08-05	2021-06-30
6-K	—	2021-07-14	—
6-K	—	2021-07-14	—
6-K	—	2021-07-12	2021-07-10
6-K	—	2021-06-23	2021-06-22
6-K	—	2021-06-08	2021-06-07
6-K	—	2021-06-04	—
6-K	—	2021-05-28	2021-05-27
6-K	—	2021-05-19	2021-05-18
6-K	—	2021-05-11	—
6-K	—	2021-05-05	2021-05-04
6-K	—	2021-05-03	2021-04-30
6-K	—	2021-04-29	—
6-K	—	2021-04-23	—
6-K	—	2021-04-09	2021-04-08

Showing 151–200 of 254 filings

Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 14 filings 14 filers Visit website Investor relations